Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
LIC MF Healthcare Fund(G)-Direct Plan
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.11.0898524369.1081
Domestic EquitiesTorrent Pharmaceuticals Ltd.6.9275131305.6896
Domestic EquitiesApollo Hospitals Enterprise Ltd.6.873072175.6448
Domestic EquitiesFortis Healthcare Ltd.4.9390430324.0564
Domestic EquitiesDivi's Laboratories Ltd.4.805161583.9464
Domestic EquitiesAurobindo Pharma Ltd.4.6512313013.8200
Domestic EquitiesPiramal Pharma Ltd.4.29792260883.5299
Domestic EquitiesNeuland Laboratories Ltd.4.036625853.3153
Domestic EquitiesOnesource Specialty Pharma Ltd.3.6337221592.9844
Domestic EquitiesAlkem Laboratories Ltd.3.438850082.8243
Domestic EquitiesCipla Ltd.3.2120195672.6380
Domestic EquitiesNavin Fluorine International Ltd.3.135541162.5752
Domestic EquitiesAbbott India Ltd.3.12699682.5681
Domestic EquitiesGlenmark Pharmaceuticals Ltd.3.1204119942.5628
Domestic EquitiesGland Pharma Ltd.3.1157140432.5589
Domestic EquitiesIPCA Laboratories Ltd.3.0909166042.5386
Domestic EquitiesConcord Biotech Ltd.3.0513205312.5060
Domestic EquitiesMetropolis Healthcare Ltd.2.7413118262.2514
Domestic EquitiesArtemis Medicare Services Ltd.2.7320935292.2438
Domestic EquitiesMankind Pharma Ltd.2.347385771.9278
Domestic EquitiesMax Healthcare Institute Ltd.2.2302167751.8317
Domestic EquitiesDr Agarwal's Health Care Ltd.2.1765395761.7876
Domestic EquitiesAnthem Biosciences Ltd.2.1630253331.7765
Domestic EquitiesGlobal Health Ltd.2.0732149521.7027
Domestic EquitiesAcutaas Chemicals Ltd.1.654962961.3592
Domestic EquitiesVinati Organics Ltd.1.566887411.2868
Total 96.2306 79.0343
Cash & Cash Equivalents and Net AssetsTreps3.9022 3.2049
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)-0.1328 -0.1091
Total 3.7694 3.0958
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.